(Q24304748)

GOA release 2020-03-11

apolipoprotein H

1 reference

regulation of fibrinolysis

GOA release 2020-03-11

1 reference

Biochimica et Biophysica Acta

GOA release 2020-03-11

1 reference

Francisco López-Lira

1

0 references

Luis Rosales-León

series ordinal

2

0 references

Verónica Monroy Martínez

series ordinal

3

0 references

Blanca H Ruiz Ordaz

series ordinal

4

0 references

language of work or name

English

0 references

publication date

April 2006

0 references

published in

0 references

volume

1764

0 references

issue

4

0 references

page(s)

815-23

0 references

cites work

Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Antibody BCF2 against scorpion toxin cn2 fromCentruroides noxius hoffmann: Primary structure and three-dimensional model as free fv fragment and complexed with its antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Low-resolution docking: prediction of complexes for underdetermined structures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Studies on the possible function of beta 2-glycoprotein-I: influence in the triglyceride metabolism in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

The antiphospholipid syndrome: ten years on.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Current insights into the "antiphospholipid" syndrome: clinical, immunological, and molecular aspects

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Participation of the Dengue virus in the fibrinolytic process

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Suppressed intrinsic fibrinolytic activity by monoclonal anti-beta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Crystallographic R factor refinement by molecular dynamics

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Beta 2-glycoprotein I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021

The Protein C Pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAPAP.2005.12.020

7 January 2021